BioPartner Market Intelligence Consortium (BioMIC)
| BioPartner.co.uk has teamed up with Thomson Reuters to offer substantially discounted subscriptions to Thomson Pharma® online for small, UK -based companies. We think that access to Thomson Pharma® will save time and money for small companies and provide a huge competitive advantage when positioning product pipelines, predicting their markets and valuations and targeting partnering, licensing and M&A opportunities. Discounted subscriptions are only available to members of BioMIC - click here for the opportunity to take up this limited offer (conditions apply). |
 |
Please note that in order to deliver this outstanding discount we need at least 5 SMEs to commit
to purchase before 1st September 2009. Each company must have less than 25 employees
Here's what Thomson Reuters have to say about the benefits of subscribing to Thomson Pharma®:
- Stay informed on the latest drugs, trials, news stories and patents.
- Receive breaking company news, with links to the full stories and press releases.
- View meeting reports and conference proceedings.
- Link at a click between different types of content.
- Pull together data from multiple sources.
- Select the homepage that matches your user type, filter content by therapy area, and choose the way you receive vital information, relevant news and update alerts.
- Edit your saved results, add comments as you need, and print, email or export them.
- Include your own third party data.
- Authoritative: Thomson Pharma covers the entire drug discovery and development pipeline - the latest drugs, compounds, genetic sequences and targets, clinical trials, patents, journals, conferences, academic articles and more.
- Relevant: The intelligence you must have, recalled instantly using intuitive guided searches, filtered as you want it, and presented in a simple, intuitive online portal.
- Dynamic: New drugs and compounds, clinical trials and deals, the latest journals, conferences, academic articles and abstracts, medical news stories and more, all indexed, cross-referenced and a click away.
- Market aware: In-depth competitive intelligence, with detailed pipeline, financial and marketing profiles of more than 7,500 pharmaceutical and biotechnology companies.
- User-focused: An easy-to-use, quick to learn, fully-customizable personal information center, integrated into your daily workflow needs with unrivalled flexibility and consistent navigation.
Our agreement with Thomson Reuters will enable you to access this valuable information at a fraction of the normal cost. Subscribers must be members of our consortium, BioMIC, in order to take advantage of the offer which is available only to UK headquartered biopharma companies with under 25 employees. Joining instructions will be provided on this website in the next few days.
Each member's online access to Thomson Pharma® will be separate from those of other members, and firewalled in the same way as a normally priced subscription. Consortium members can choose to keep their membership confidential. BioPartner.co.uk Ltd reserve the right to charge a small administration fee to each subscriber.
For more information, go to the Thomson Pharma® weblink
or contact us:
Email: info@biopartner.co.uk
Tel: 01865 784737
